This book explores the role of pharmacogenomics in optimizing stroke treatments. It covers genetic factors that influence responses to thrombolytics, antiplatelet agents, and anticoagulants. The text emphasizes personalized approaches to improve stroke outcomes and reduce recurrence risks through genetic insights. Targeted at neurologists and pharmacogenomic specialists, it promotes tailored therapies in stroke management.
Lauren Simpson applies pharmacogenomics to manage stroke-related dermatological conditions, such as pressure ulcers and post-stroke spasticity-induced skin issues. Her research explores how genetic variations affect responses to treatments used in managing skin conditions following a stroke. Lauren has authored numerous studies on personalizing dermatological care for stroke patients through pharmacogenomic testing to improve outcomes and reduce complications. She also offers guidelines for clinicians to incorporate pharmacogenomic insights into managing stroke-related skin conditions, promoting personalized and effective dermatological care through genetic-informed strategies.